Surging EV adoption has allowed Chinese automotive and technology firms to slash the costs of building electric cars with L4 capabilities, according to Paul Gong, head of China automotive research at Swiss bank UBS.
Felis consequat magnis est fames sagittis ultrices placerat sodales porttitor quisque.
Surging EV adoption has allowed Chinese automotive and technology firms to slash the costs of building electric cars with L4 capabilities, according to Paul Gong, head of China automotive research at Swiss bank UBS.
Chinese contract drug makers – including WuXi AppTec, WuXi Biologics and WuXi XDC – face a less certain long-term revenue outlook as US pharmaceutical companies bring production in-house and reconfigure…
China leads the world in patent applications for anti-drone technology, which has drawn heightened attention during the wars in Ukraine and Iran and a spate of suspicious sightings in the…